Streetbeat News

Stock Prices

DKNG

DraftKings shares are trading lower after the company reported mixed Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 2:15 pm

SNAP

Snap Inc. (NYSE:SNAP) shares plummeted after the company reported a revenue miss for Q2, with revenue increasing 16% year-over-year to $1.24 billion, falling short of the $1.25 billion expected by analysts. The company also reported negative operating and free cash flow. Despite a 9% increase in daily active users, multiple analysts have lowered their price targets for Snap. The stock is trading well below its 50-day moving average and is down 22.98% to $9.86.

Portfolio Pulse from Erica Kollmann

August 02, 2024 | 2:15 pm

MTD

Mettler-Toledo shares are trading lower after the company reported Q2 financial results and issued Q3 adjusted EPS guidance below estimates.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 2:12 pm

AMH

American Homes 4 Rent shares are trading higher after the company reported better-than-expected Q2 revenue and FFO results. Additionally, the company raised its FY24 core FFO guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 2:08 pm

PRU

Prudential Financial shares are trading lower after the company reported worse-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 2:06 pm

LYB

LyondellBasell Industries (NYSE: LYB) reported strong Q2 fiscal 2024 results, with revenues of $10.55 billion and adjusted EPS of $2.24, both beating consensus estimates. Despite a slight contraction in margins, the company saw increased production and favorable cost conditions. LYB provided optimistic margin guidance for Q3, expecting continued benefits from low natural gas costs. The company also reported strong cash flow and significant investments, including a stake in the NATPET joint venture.

Portfolio Pulse from Akanksha Bakshi

August 02, 2024 | 2:03 pm

RKT

In the last three months, 4 analysts have published ratings on Rocket Companies (NYSE:RKT), with a mix of 'Indifferent' and 'Somewhat Bearish' sentiments. The average 12-month price target has increased to $12.88, reflecting a 14.49% rise from the previous target. Analysts from Wedbush, Barclays, JP Morgan, and Piper Sandler have raised their price targets, indicating a cautiously optimistic outlook.

Portfolio Pulse from Benzinga Insights

August 02, 2024 | 2:01 pm

REGN

Regeneron Pharmaceuticals (NASDAQ:REGN) has been analyzed by 14 analysts over the last quarter, showing a range of sentiments from bullish to bearish. The average 12-month price target has increased by 7% to $1172.0. Recent analyst actions include several rating raises and price target increases, reflecting positive sentiment despite a slight revenue decline.

Portfolio Pulse from Benzinga Insights

August 02, 2024 | 2:01 pm

TWST

Twist Bioscience Corporation (NASDAQ: TWST) reported a third-quarter adjusted EPS loss of $(0.70), beating the consensus of $(0.77). The company also reported a 27.8% year-over-year increase in sales to $81.5 million, surpassing both the consensus and management guidance. Twist Bioscience raised its sales guidance for fiscal 2024 and expects to achieve a gross margin of over 50% by the end of fiscal 2025. Despite the positive earnings report, TWST stock was down 13.21% at $46.04.

Portfolio Pulse from Vandana Singh

August 02, 2024 | 2:01 pm

OCSL

Analysts have provided mixed ratings for Oaktree Specialty Lending (NASDAQ:OCSL) over the past three months, with recent adjustments reflecting a more cautious outlook. The average 12-month price target has decreased by 6.77%, and several analysts have lowered their price targets and ratings. Financial performance indicators show challenges in revenue growth, ROE, and ROA, despite a strong net margin.

Portfolio Pulse from Benzinga Insights

August 02, 2024 | 2:01 pm